Type 2 diabetes patients with no previous cardiovascular disease who were on low-dose aspirin treatment did not show a lower risk of cardiovascular disease or death at 3.9 years compared with nonusers, according to a study in BMJ Open. Researchers noted a slightly increased risk of both fatal and non-fatal heart disease in female aspirin users compared with women who did not take the drug.

Full Story:

Related Summaries